
DiaMedica Therapeutics Inc (DMAC)
US$ 4.32.99%
Price Chart
Key Statistics
Market Cap
$ 174.42M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
27.79K
52W High
$ 6.82
52W Low
$ 2.14
Dividend Yield
0.00%
Beta
1.29
Technicals
50-Day MA
4.2875
200-Day MA
4.6881
52 Week High
6.8184
52 Week Low
2.14
About DMAC
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases.
Employees
27
Headquarters
Minneapolis, MN
CEO
Mr. Dietrich John Pauls MBA
Latest News
Annual DMAC Festival slated for Saturday in Athens - WAFF
3 weeks ago • Google News
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q1 2025 Earnings Call Transcript - Insider Monkey
Yesterday • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg